Highlights from the Crohn’s & Colitis Congress™

AGA and the Crohn’s & Colitis Foundation hosted the inaugural Crohn’s & Colitis Congress on Jan. 18-20, 2018, in Las Vegas, Nevada. The new annual inflammatory bowel diseases (IBD) Congress served as the premier conference for IBD health care professionals and...

2017 AGA Biosimilars Roundtable

The AGA Center for Diagnostics and Therapeutics was pleased to host the AGA Biosimilars Roundtable on Dec. 3-4, 2017, in Washington, D.C. In attendance were 26 invited experts representing academic and private practice physicians from the U.S., Europe, and Canada,...

AGA’s Investment in the Future of GI

AGA — through the AGA Research Foundation — has made a commitment to support investigators in GI and hepatology with its Research Awards Program. In the past year, the foundation provided $2.2 million in research funding to 52 highly qualified investigators. These...

Birth-cohort Testing IDs Undiagnosed HCV

Birth-cohort testing is helping identify people who have undiagnosed hepatitis C (HCV) infection, but significant numbers don’t get treatment due to gaps in linkage to care. In 2012 the Centers for Disease Control and Prevention (CDC) introduced recommendations...